335 related articles for article (PubMed ID: 25797075)
1. Efficacy of Surgery and Further Treatment of Progressive Glioblastoma.
Woernle CM; Péus D; Hofer S; Rushing EJ; Held U; Bozinov O; Krayenbühl N; Weller M; Regli L
World Neurosurg; 2015 Aug; 84(2):301-7. PubMed ID: 25797075
[TBL] [Abstract][Full Text] [Related]
2. Residual tumor volume and patient survival following reoperation for recurrent glioblastoma.
Yong RL; Wu T; Mihatov N; Shen MJ; Brown MA; Zaghloul KA; Park GE; Park JK
J Neurosurg; 2014 Oct; 121(4):802-9. PubMed ID: 25061868
[TBL] [Abstract][Full Text] [Related]
3. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
4. γ knife surgery versus reoperation for recurrent glioblastoma multiforme.
Skeie BS; Enger PØ; Brøgger J; Ganz JC; Thorsen F; Heggdal JI; Pedersen PH
World Neurosurg; 2012 Dec; 78(6):658-69. PubMed ID: 22484078
[TBL] [Abstract][Full Text] [Related]
5. Impact of removed tumor volume and location on patient outcome in glioblastoma.
Awad AW; Karsy M; Sanai N; Spetzler R; Zhang Y; Xu Y; Mahan MA
J Neurooncol; 2017 Oct; 135(1):161-171. PubMed ID: 28685405
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of Reintervention in Recurrent Glioblastoma: An Indispensable Weapon for Increasing Survival.
Delgado-Fernandez J; Garcia-Pallero MÁ; Blasco G; Penanes JR; Gil-Simoes R; Pulido P; Sola RG
World Neurosurg; 2017 Dec; 108():610-617. PubMed ID: 28939537
[TBL] [Abstract][Full Text] [Related]
7. The relationship between repeat resection and overall survival in patients with glioblastoma: a time-dependent analysis.
Goldman DA; Hovinga K; Reiner AS; Esquenazi Y; Tabar V; Panageas KS
J Neurosurg; 2018 Nov; 129(5):1231-1239. PubMed ID: 29303449
[TBL] [Abstract][Full Text] [Related]
8. Reoperation for Recurrent Glioblastoma and Its Association With Survival Benefit.
Tully PA; Gogos AJ; Love C; Liew D; Drummond KJ; Morokoff AP
Neurosurgery; 2016 Nov; 79(5):678-689. PubMed ID: 27409404
[TBL] [Abstract][Full Text] [Related]
9. Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma.
Sun MZ; Oh T; Ivan ME; Clark AJ; Safaee M; Sayegh ET; Kaur G; Parsa AT; Bloch O
J Neurosurg; 2015 May; 122(5):1144-50. PubMed ID: 25768833
[TBL] [Abstract][Full Text] [Related]
10. Glioblastoma in the elderly: the impact of advanced age on treatment and survival.
Mariniello G; Peca C; De Caro Mdel B; Giamundo A; Donzelli R; Maiuri F
J Neurol Surg A Cent Eur Neurosurg; 2014 Jul; 75(4):276-81. PubMed ID: 24390930
[TBL] [Abstract][Full Text] [Related]
11. The impact of surgery on survival after progression of glioblastoma: A retrospective cohort analysis of a contemporary patient population.
Sastry RA; Shankar GM; Gerstner ER; Curry WT
J Clin Neurosci; 2018 Jul; 53():41-47. PubMed ID: 29680441
[TBL] [Abstract][Full Text] [Related]
12. Pre-Operative Perfusion Skewness and Kurtosis Are Potential Predictors of Progression-Free Survival after Partial Resection of Newly Diagnosed Glioblastoma.
Paik W; Kim HS; Choi CG; Kim SJ
Korean J Radiol; 2016; 17(1):117-26. PubMed ID: 26798224
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of radiotherapy for elderly patients with glioblastoma.
Scott J; Tsai YY; Chinnaiyan P; Yu HH
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):206-10. PubMed ID: 20675068
[TBL] [Abstract][Full Text] [Related]
14. The impact of inpatient rehabilitation on function and survival of newly diagnosed patients with glioblastoma.
Roberts PS; Nuño M; Sherman D; Asher A; Wertheimer J; Riggs RV; Patil CG
PM R; 2014 Jun; 6(6):514-21. PubMed ID: 24384359
[TBL] [Abstract][Full Text] [Related]
15. Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trial.
Suchorska B; Weller M; Tabatabai G; Senft C; Hau P; Sabel MC; Herrlinger U; Ketter R; Schlegel U; Marosi C; Reifenberger G; Wick W; Tonn JC; Wirsching HG
Neuro Oncol; 2016 Apr; 18(4):549-56. PubMed ID: 26823503
[TBL] [Abstract][Full Text] [Related]
16. An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.
Oppenlander ME; Wolf AB; Snyder LA; Bina R; Wilson JR; Coons SW; Ashby LS; Brachman D; Nakaji P; Porter RW; Smith KA; Spetzler RF; Sanai N
J Neurosurg; 2014 Apr; 120(4):846-53. PubMed ID: 24484232
[TBL] [Abstract][Full Text] [Related]
17. Neurosurgical management and prognosis of patients with glioblastoma that progresses during bevacizumab treatment.
Clark AJ; Lamborn KR; Butowski NA; Chang SM; Prados MD; Clarke JL; McDermott MW; Parsa AT; Berger MS; Aghi MK
Neurosurgery; 2012 Feb; 70(2):361-70. PubMed ID: 21841523
[TBL] [Abstract][Full Text] [Related]
18. Surgery for Glioblastoma: Impact of the Combined Use of 5-Aminolevulinic Acid and Intraoperative MRI on Extent of Resection and Survival.
Coburger J; Hagel V; Wirtz CR; König R
PLoS One; 2015; 10(6):e0131872. PubMed ID: 26115409
[TBL] [Abstract][Full Text] [Related]
19. Factors impacting survival following second surgery in patients with glioblastoma in the temozolomide treatment era, incorporating neutrophil/lymphocyte ratio and time to first progression.
McNamara MG; Lwin Z; Jiang H; Templeton AJ; Zadeh G; Bernstein M; Chung C; Millar BA; Laperriere N; Mason WP
J Neurooncol; 2014 Mar; 117(1):147-52. PubMed ID: 24469854
[TBL] [Abstract][Full Text] [Related]
20. Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution.
Azoulay M; Santos F; Shenouda G; Petrecca K; Oweida A; Guiot MC; Owen S; Panet-Raymond V; Souhami L; Abdulkarim BS
J Neurooncol; 2017 May; 132(3):419-426. PubMed ID: 28374095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
